Literature DB >> 35536517

A Comparative Analysis of Different HIV Viral Load Suppression Definitions Among Clients Receiving Care in the Miami-Dade Ryan White HIV/AIDS Program.

Semiu O Gbadamosi1, Mary Jo Trepka1,2, Rahel Dawit1, Zoran Bursac3, Andrea Raymond4, Robert A Ladner5, Diana M Sheehan6,7,8.   

Abstract

The study's objective was to examine variations in viral load (VL) suppression definitions among clients in the Ryan White Program (RWP). Data from clients enrolled in the RWP during 2017 were examined to calculate the proportion of virally suppressed clients using three definitions: recent viral suppression, defined as having a suppressed VL (< 200 copies/mL) in the last test in 2017; maintained viral suppression, having a suppressed VL for both the first and last tests in 2017; and sustained viral suppression, having all tests in 2017 showing suppression. Relative differences across all three definitions were computed. Recent viral suppression measures were higher than maintained and sustained viral suppression measures by 7.0% and 10.1%, respectively. Significant relative differences in definitions by demographic, socioeconomic and clinical status were observed. It may be beneficial for care planning to report not only estimates of recent viral suppression but maintained and sustained viral suppression as well.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  HIV; Ryan White Program; Sustained; Viral load; Viral suppression

Mesh:

Year:  2022        PMID: 35536517      PMCID: PMC9561086          DOI: 10.1007/s10461-022-03694-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  45 in total

1.  Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?

Authors:  Sandrine Henard; Eliette Jeanmaire; Yohan Nguyen; Yazdan Yazdanpanah; Antoine Cheret; Bruno Hoen; David Rey; Alice Borel; Pascal Chavanet; Thierry May; Christian Rabaud
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

2.  Racial and Ethnic Differences in Viral Suppression Among HIV-Positive Women in Care.

Authors:  Ndidi Nwangwu-Ike; Emma L Frazier; Nicole Crepaz; Yunfeng Tie; Madeline Y Sutton
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

Review 3.  Epidemiology of treatment failure: a focus on recent trends.

Authors:  Mark W Hull; Viviane D Lima; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  Curr Opin HIV AIDS       Date:  2009-11       Impact factor: 4.283

4.  Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications.

Authors:  Gary Marks; Unnati Patel; Michael J Stirratt; Michael J Mugavero; William C Mathews; Thomas P Giordano; Nicole Crepaz; Lytt I Gardner; Cynthia Grossman; Jessica Davila; Meg Sullivan; Charles E Rose; Christine OʼDaniels; Allan Rodriguez; Andrew J Wawrzyniak; Matthew R Golden; Shireesha Dhanireddy; Jacqueline Ellison; Mari-Lynn Drainoni; Lisa R Metsch; Edward R Cachay
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

5.  Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Authors:  I C Marschner; A C Collier; R W Coombs; R T D'Aquila; V DeGruttola; M A Fischl; S M Hammer; M D Hughes; V A Johnson; D A Katzenstein; D D Richman; L M Smeaton; S A Spector; M S Saag
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

6.  Brief Report: Clinical Outcomes of Young Black Men Receiving HIV Medical Care in the United States, 2009-2014.

Authors:  Pranesh Chowdhury; Linda Beer; R Luke Shouse; Heather Bradley
Journal:  J Acquir Immune Defic Syndr       Date:  2019-05-01       Impact factor: 3.731

7.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

8.  Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States.

Authors:  Medha Vyavaharkar; Linda Moneyham; Sara Corwin; Ruth Saunders; Lucy Annang; Abbas Tavakoli
Journal:  J Assoc Nurses AIDS Care       Date:  2009-10-30       Impact factor: 1.354

9.  Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Melanie A Thompson; Michael A Horberg; Allison L Agwu; Jonathan A Colasanti; Mamta K Jain; William R Short; Tulika Singh; Judith A Aberg
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

10.  Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

Authors:  Margaret T May; Mark Gompels; Valerie Delpech; Kholoud Porter; Chloe Orkin; Stephen Kegg; Phillip Hay; Margaret Johnson; Adrian Palfreeman; Richard Gilson; David Chadwick; Fabiola Martin; Teresa Hill; John Walsh; Frank Post; Martin Fisher; Jonathan Ainsworth; Sophie Jose; Clifford Leen; Mark Nelson; Jane Anderson; Caroline Sabin
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.